India always needs a PM like Modi; he is a true statesman: Poojary

New Delhi, June 27: The Prime Minister Narendra Modi-led union government of India is not ready to stop all imports from aggressive China in spite of mount calls to boycott Chinese products in India.

The Centre is reportedly considering to stop only non-essential imports from the neighbouring country.

However, the Inward shipment in sectors such as automobiles, pharmaceuticals, certain electronics and others will continue until a domestic alternative is found.

“India will gradually move towards import substitution. It will not happen overnight. In the meantime, attention has to be paid on production and job creation. We cannot throttle our industry. There are certain absolutely essential imports. Needless to say, those will keep going,” official sources said.

Sources said that both the government and the industry are in the process of identifying products that can be domestically manufactured in the medium term. There are certain chemicals, automotive components, handicrafts, cosmetics, agriculture items and certain consumer electronics, which can be manufactured domestically in the short to medium term. The government is doing all it can to raise the capacity of domestic industries.

However, there are certain other imports in the automobile and the pharmaceutical sectors which cannot be done away within the short to medium term. Their domestic production at the moment may not be that cost-effective.

The six-crore strong traders’ body CAIT has been at the forefront of such a demand and has launched a campaign to celebrate Indian Diwali this year with a total absence of Chinese goods.

“Ease of doing business, capital availability at lower rates and globally competitive logistics and energy costs are some of the prerequisites that the government should look into to ensure the growth of the domestic auto component industry,” according to Automotive Component Manufacturers Association of India (ACMA) Director General Vinnie Mehta.

Maruti Suzuki Chairman R C Bhargava said, “People who are boycotting Chinese goods have to remember that in some cases it may lead to their being asked to pay more for the same product."

Meanwhile, domestic rating agency Acuite Ratings & Research has analysed the current import portfolio from China and found 40 sub-sectors have the potential to lower their import dependency on China. These sectors contribute to $33.6 billion worth of imports from China and about 25% of these imports can be substituted by local manufacturing without any significant additional investments.

Bengaluru, Jun 21: As many as 518 private hospitals and medical colleges empanelled under the Suvarna Arogya Suraksha Trust (SAST) have been allowed to treat Covid-19 patients in Karnataka amid rising cases, an official said on Saturday.

"These 518 institutions across the state empanelled under ABArK are permitted to admit and treat Covid patients as per government protocols and criteria," the health official said.

The private hospitals can treat patients only if referred by public authorities such as BBMP Commissioner, Health department Director, District Health Officers and others.

In Bengaluru, there are 44 such empanelled private facilities. The entire list is available at www.arogya.karnataka.gov.in and also on the Health Department's website.

The hospitals will be paid an appropriate package rate for Covid management, said the official.

The state has not barred private hospitals from treating Covid patients but they have to mandatorily report all positive cases.

"Due to increasing number of Covid cases in the state, it was decided to involve private hospitals in treatment of such patients," said Additional Chief Secretary Jawaid Akhtar.

Also Read: These private hospitals in Mangaluru and Udupi can now treat covid patients